Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Saike Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). Founded in 2004 and headquartered in Haikou, the company operates as a key subsidiary of the state-owned China Meheco Group. Its product portfolio is primarily focused on high-end generics within therapeutic areas such as cardiovascular health, anti-infectives, and gastrointestinal disorders. The company maintains modern manufacturing facilities that comply with international GMP standards, supporting both domestic supply and export markets. Saike Pharmaceutical is recognized for its integration of R&D with industrial production, particularly in the synthesis of complex small molecule therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Saike Pharmaceutical.